People · Operator

Dan S Ellis

Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology

1
Companies
1
Filings
$72.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Align Technology IncBiotechnologySeries C$72.3M$3.0B2009
Operator network

Dan S Ellis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Joseph Lacob · 4 companies · 1 sharedJoseph LacobThomas M. Prescott · 4 companies · 1 sharedThomas M. PrescottC. Raymond Larkin, Jr. · 2 companies · 1 sharedC. Raymond Larkin…Len Hedge · 2 companies · 1 sharedLen HedgeDana C Cambra · 1 companies · 1 sharedDana C CambraDavid E Collins · 1 companies · 1 sharedDavid E CollinsDavid Nagel · 1 companies · 1 sharedDavid NagelEmory Wright · 1 companies · 1 sharedEmory WrightGeorge J Morrow · 1 companies · 1 sharedGeorge J MorrowGil Laks · 1 companies · 1 sharedGil LaksGreg J Santora · 1 companies · 1 sharedGreg J SantoraKenneth B Arola · 1 companies · 1 sharedKenneth B ArolaRoger E George · 1 companies · 1 sharedRoger E GeorgeSheila Tan · 1 companies · 1 sharedSheila TanWarren S Thaler · 1 companies · 1 sharedWarren S ThalerAlign Technology Inc · $72.3M raisedAlign Technology IncDan S EllisDE
Dan S Ellis Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Dan S Ellis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Thomas M. Prescott14
Joseph Lacob14
Len Hedge12
C. Raymond Larkin, Jr.12
Warren S Thaler11
Dana C Cambra11
Sheila Tan11
George J Morrow11
Emory Wright11
David Nagel11
Roger E George11
Greg J Santora11
Gil Laks11
Kenneth B Arola11
David E Collins11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.